Search research articles
Contact Us
Filters
Showing results (371-380 of 442) with videos related to
Page
of 45
Sort By:
Plos One
|
September 3, 2010
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells
Ann H Klopp, Lara Lacerda, Anshul Gupta, et al.
Cancer Letters
|
November 22, 2024
Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling
Lorenzo Gerratana, Andrew A Davis, Lorenzo Foffano, et al.
The Oncologist
|
August 7, 2023
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents
Eleonora Nicolò, Paolo Tarantino, Oriana D'Ecclesiis, et al.
Breast Cancer Research and Treatment
|
May 5, 2019
Elevated serum levels of sialyl Lewis X (sLe<sup>X</sup>) and inflammatory mediators in patients with breast cancer
Evan N Cohen, Tamer M Fouad, Bang-Ning Lee, et al.
Theranostics
|
March 10, 2022
Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior
Alba Rodriguez-Martinez, Iris Simon-Saez, Sonia Perales, et al.
Molecular Cancer
|
July 10, 2010
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells
Bisrat G Debeb, Xiaomei Zhang, Savitri Krishnamurthy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Catherine Van Poznak, Mark R Somerfield, Robert C Bast, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study
Massimo Cristofanilli, Hope S Rugo, Seock-Ah Im, et al.
Breast Cancer Research and Treatment
|
May 29, 2025
Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes
Arielle J Medford, Marko Velimirovic, Yifat Gefen, et al.
Journal of the National Cancer Institute
|
May 15, 2020
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis
Francesco Schettini, Fabiola Giudici, Mario Giuliano, et al.
Page
of 45
Search research articles
Search
Showing results (371-380 of 442) with videos related to
Sort By:
Page
of 45
Plos One
|
September 3, 2010
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells
Ann H Klopp, Lara Lacerda, Anshul Gupta, et al.
Cancer Letters
|
November 22, 2024
Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling
Lorenzo Gerratana, Andrew A Davis, Lorenzo Foffano, et al.
The Oncologist
|
August 7, 2023
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents
Eleonora Nicolò, Paolo Tarantino, Oriana D'Ecclesiis, et al.
Breast Cancer Research and Treatment
|
May 5, 2019
Elevated serum levels of sialyl Lewis X (sLe<sup>X</sup>) and inflammatory mediators in patients with breast cancer
Evan N Cohen, Tamer M Fouad, Bang-Ning Lee, et al.
Theranostics
|
March 10, 2022
Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior
Alba Rodriguez-Martinez, Iris Simon-Saez, Sonia Perales, et al.
Molecular Cancer
|
July 10, 2010
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells
Bisrat G Debeb, Xiaomei Zhang, Savitri Krishnamurthy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Catherine Van Poznak, Mark R Somerfield, Robert C Bast, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study
Massimo Cristofanilli, Hope S Rugo, Seock-Ah Im, et al.
Breast Cancer Research and Treatment
|
May 29, 2025
Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes
Arielle J Medford, Marko Velimirovic, Yifat Gefen, et al.
Journal of the National Cancer Institute
|
May 15, 2020
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis
Francesco Schettini, Fabiola Giudici, Mario Giuliano, et al.
Page
of 45